RecruitingNot ApplicableNCT07352982

Transcutaneous Tibial Nerve Stimulation on Women With Primary Dysmenorrhea

Effect of Transcutaneous Tibial Nerve Stimulation on Women With Primary Dysmenorrhea

Sponsor

Kafrelsheikh University

Enrollment

32 participants

Start Date

Jan 19, 2026

Study Type

INTERVENTIONAL

Conditions

Women Transcutaneous Tibial Nerve Stimulation Primary Dysmenorrhea

Summary

This study aims to investigate the effects of transcutaneous tibial nerve stimulation (TTNS) on women with primary dysmenorrhea (PD).

Eligibility

Sex: FEMALEMin Age: 20 YearsMax Age: 25 Years

Inclusion Criteria5

Age ranges from 20-25 years old.
Body mass index (BMI) doesn't exceed 30 kg/m2.
Patients referred from a Gynecologist with a diagnosis of Primary Dysmenorrhea (PD).
Patients have regular menstrual cycles.
Patients suffer from pain located in the suprapubic area, abdomen, lower lumbar area, perineum, and/or medial aspect of the thighs during at least half of their annual menstrual cycles and/or in the last 3 cycles.

Exclusion Criteria7

Patients diagnosed with gynecological pathology.
Patients taking oral contraceptives or had an intrauterine device implanted.
Patients had bad obstetric situations or diseases that could interfere with participation.
Patients have certain disorders including uncorrected coagulopathies, severe comorbid disorder, cancer in the last 5 years or at present, presence of erosions on the inner aspect of the ankle, severe mental disorders, or neuropathies affecting the lower limb.
Patients who are smoking or taking oral sedatives.
Patients had undergone surgery or childbirth in the last 6 months.
Patients who are pregnant.

Interventions

OTHERTranscutaneous tibial nerve stimulation (TTNS)

Patients will receive the transcutaneous tibial nerve stimulation (TTNS) and traditional treatment (Nonsteroidal anti-inflammatory drugs) for three sessions a week for four consecutive weeks.

DRUGTraditional treatment (Nonsteroidal anti-inflammatory drugs)

Patients will receive the placebo transcutaneous tibial nerve stimulation (TTNS) and traditional treatment (Nonsteroidal anti-inflammatory drugs) for three sessions a week for four consecutive weeks.